Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22Thoracic 5Gynecologic 5Head & Neck 4Genitourinary 4Other 3Tumor-Agnostic 2Endocrine 2Sarcoma 1Other neoplasm 1NET 1Breast 1

Conditions

Gastrointenstinal Stromal Tumor (GIST) 1

Interventions

Radiotherapy 220Doxorubicin 210Cyclophosphamide 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 80Irinotecan 79pembrolizumab 75Radiation 69Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 57Surgical Procedures, Operative 56Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Robotic Surgical Procedures × Sarcoma × Clear all
NCT07405125 2026-02-12

Safety of Robotic Surgery for GISTs at Special Anatomic Sites

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
182 enrolled
Sarcoma

Gastrointenstinal Stromal Tumor (GIST)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡